Titelia

Holdings of Kalehua Capital Management LLC

· Original filing · Compare with another fund · Report an error

Net assets
-
Positions
21 in 2 countries
Top ten
80.0 % of the equity sleeve
Filed on
Mar 31, 2026
Portfolio shape

Positions

RankCompanySharesValueWeight
1Alpha Architect 1-3 Month Box 218,27825.4M $
2X4 Pharmaceuticals Inc 3,722,84015.4M $
3Surrozen Inc 385,17811.2M $
4VERADERMICS INC 145,6959.2M $
5Relay Therapeutics Inc 901,4579M $
6Sionna Therapeutics Inc 197,0727.9M $
7Aclaris Therapeutics Inc 1,832,3656.9M $
8Inhibikase Therapeutics Inc 3,821,8906.4M $
9ORUKA THERAPEUTICS INC 118,5245.8M $
10Septerna Inc 194,5444.7M $
11COMPASS PATHWAYS PLC 819,6924.5M $
12LeonaBio Inc 393,7014M $
13DAMORA THERAPEUTICS INC 139,0003.6M $
14Gossamer Bio Inc 10,236,2933.4M $
15TYRA BIOSCIENCES INC 74,4652.9M $
16PepGen Inc 1,000,0001.8M $
17Instil Bio Inc 183,0301.5M $
18TENAYA THERAPEUTICS INC 2,000,0001.4M $
19Korro Bio Inc 109,3761.2M $
20Kalaris Therapeutics Inc 135,585782.3K $
21LOOP INDUSTRIES INC 347,539361.4K $

Download this table: CSV, JSON

Tell me about updates

Sector breakdown

  • Unattributed 100.0 %

Titelia assigns each company to a sector, one by one. The unassigned share stays visible, under "Unattributed".

Currency breakdown

  • USD 100.0 %

Each line is counted in its quoted currency, as the fund declares it.

Country breakdown

  • United States 96.4 %
  • United Kingdom 3.6 %

Shares are computed on the fund's equities only.

RankCountryLinesValueShare
1United States20122.7M $96.44 %
2United Kingdom14.5M $3.56 %
Cite this page

Titelia. "Holdings of Kalehua Capital Management LLC". https://titelia.com/en/funds/US13F2106181